[1] |
De Bree A,Verschuren WM,Kromhout D,et al.Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease[J].Pharmacol Rev,2002,54(4):599-618.
|
[2] |
Zhou J,Austin RC.Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms[J].Biofactors,2009,35(2):120-129.
|
[3] |
Singh Y,Samuel VP,Dahiya S,et al.Combinational effect of angiotensin receptor blocker and folic acid therapy on uric acid and creatinine level in hyperhomocysteinemia-associated hypertension[J].Biotechnol Appl Biochem,2019,66(5):715-719.
|
[4] |
McCully KS.Vascular pathology of homocysteinemia:implications for the pathogenesis of arteriosclerosis[J].Am J Pathol,1969,56(1):111-128.
|
[5] |
Zhou Z,Liang Y,Qu H,et al.Plasma homocysteine concentrations and risk of intracerebral hemorrhage: a systematic review and meta-analysis[J].Sci Rep,2018,8(1):2568.
|
[6] |
Esse R,Barroso M,Tavares de Almeida I,et al.The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art[J].Int J Mol Sci,2019,20(4):530-533.
|
[7] |
张英,崇丽宁,李继梅.脑出血与同型半胱氨酸的临床相关性分析[J].中国卒中杂志,2017,12(8):691-695.
|
[8] |
Li Z,Sun L,Zhang H,et al.Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke,but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke:a multicenter case-control study in China[J].Stroke,2003,34(9):2085-2090.
|
[9] |
Zhou Z,Liang Y,Qu H,et al.Plasma homocysteine concentrations and risk of intracerebral hemorrhage: a systematic review and meta-analysis[J].Sci Rep,2018,8(1):2568.
|
[10] |
Zhou F,Chen B,Chen C,et al.Elevated homocysteine levels contribute to larger hematoma volume in patients with intracerebral hemorrhage[J].J Stroke Cerebrovasc Dis,2015,24(4):784-788.
|
[11] |
Ribo M,Montaner J,Monasterio J,et al.Role of homocysteine in the acute phase of stroke[J].Neurologia,2004,19(1):10-14.
|
[12] |
胡大一,徐希平.有效控制"H型"高血压——预防卒中的新思路[J].中华内科杂志,2008,47(12):976-977.
|
[13] |
Graham ILE,Daly LE,Refsum HM,et al.Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project[J].JAMA,1997,277(22):1775-1781.
|
[14] |
秦青通,张丹红.血浆同型半胱氨酸与原发性高血压及脑出血的关系[J].中国危重病急救医学,2003,15(9):518-518.
|
[15] |
Abidi O,Haissam M,Nahili H,et al.Methylenetetrahydrofolate reductase gene polymorphisms(C677T and A1298C) and hemorrhagic stroke in moroccan patients[J].J Stroke Cerebrovasc Dis,2018,27(7):1837-1843.
|
[16] |
Lominadze D,Roberts AM,Tyagi N,et al.Homocysteine causes cerebrovascular leakage in mice[J].Am J Physiol Heart Circ Physiol,2006,290(3):1206-1213.
|
[17] |
Brinckerhoff CE,Matrisian LM.Matrix metalloproteinases:a tail of a frog that became a prince[J].Nat Rev Mol Cell Biol,2002,3(3):207-214.
|
[18] |
Koh SH,Park CY,Kim MK,et al.Microbleeds and free active MMP-9 are independent risk factors for neurological deterioration in acute lacunar stroke[J].Eur J Neurol,2011,18(1):158-164.
|
[19] |
Lei C,Lin S,Zhang C,et al.Activation of cerebral recovery by matrix metalloproteinase-9 after intracerebral hemorrhage[J].Neuroscience,2013,230(11):86-93.
|
[20] |
Gao D,Ding F,Lei G,et al.Effects of focal mild hypothermia on thrombin-induced brain edema formation and the expression of protease activated receptor-1,matrix metalloproteinase-9 and aquaporin 4 in rats[J].Mol Med Rep,2015,11(4):3009-3014.
|
[21] |
Tyagi N,Gillespie WJC,Vacek JC,et al.Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway[J].J Cell Physiol,2009,220(1):257-266.
|
[22] |
Min H,Hong J,Cho IH,et al.TLR2-induced astrocyte MMP9 activation compromises the blood brain barrier and exacerbates intracerebral hemorrhage in animal models[J].Mol Brain,2015,8(3):23-26.
|
[23] |
Xu Y,Tian Y,Wei HJ,et al.Methionine diet-induced hyperhomocysteinemia accelerates cerebral aneurysm formation in rats[J].Neurosci Lett,2011,494(2):139-144.
|
[24] |
Korai M,Kitazato KT,Tada Y,et al.Hyperhomocysteinemia induced by excessive methionine intake promotes rupture of cerebral aneurysms in ovariectomized rats[J].J Neuroinflammation,2016,13(1):165.
|
[25] |
Ren JR,Ren SH,Ning B,et al.Hyperhomocysteinemia as a risk factor for saccular intracranial aneurysm:a cohort study in a chinese han population[J].J Stroke Cerebrovasc Dis,2017,26(12):2720-2726.
|
[26] |
Rosi J,Morais BA,Pecorino LS,et al.Hyperhomocysteinemia as a risk factor for intracranial aneurysms:a case-control study[J].World Neurosurg,2018,119(17):e272-e275.
|
[27] |
Chen SJ,Tsai HH,Tsai LK,et al.Advances in cerebral amyloid angiopathy imaging[J].Ther Adv Neurol Disord,2019,12(1):113-117.
|
[28] |
Hineno A,Ikeda S.Cerebral amyloid angiopathy[J].Nihon Rinsho,2011,11(5):140-147.
|
[29] |
Lee SS,Stemmermann GN.Congophilic angiopathy and cerebral hemorrhage[J].Arch Pathol Lab Med,1978,102(6):317-321.
|
[30] |
Sakai K,Ueda M,Fukushima W,et al.Nationwide survey on cerebral amyloid angiopathy in Japan[J].Eur J Neurol,2019,26(12):1487-1493.
|
[31] |
Li JG,Praticò D.High levels of homocysteine results in cerebral amyloid angiopathy in mice[J].J Alzheimers Dis,2015,43(1):29-35.
|
[32] |
吴志武.急性缺血性脑卒中静脉溶栓后早期改善脑血循环治疗研究进展[J].中国医学创新,2019,16(18):164-167.
|
[33] |
Powers WJ,Rabinstein AA,Ackerson T,et al. Guidelines for the early management of patients with acute ischemic stroke:2019 update to the 2018 guidelines for the early management of acute ischemic stroke:a guideline for healthcare professionals from the american heart association/american stroke association[J].Stroke,2019,50(12):344-418.
|
[34] |
Asahi M,Wang X,Mori T,et al.Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia[J].J Neurosci,2001,21(19):7724-7732.
|
[35] |
Fujimura M,Gasche Y,Morita-Fujimura Y,et al.Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion[J].Brain Res,1999,842(1):92-100.
|
[36] |
Rosenberg GA,Cunningham LA,Wallace J,et al.Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain:activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures[J].Brain Res,2001,893(15):104-112.
|
[37] |
Sumii T,Lo EH.Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats[J].Stroke,2002,33(3):831-836.
|
[38] |
Yao ES,Tang Y,Xie MJ,et al.Elevated homocysteine level related to poor outcome after thrombolysis in acute ischemic stroke[J].Med Sci Monit,2016,22(17):3268-3273.
|
[39] |
Ling-Cong,Hong-Zhao,Yu-Wang,et al.The serum homocysteine level in patients with acute ischemic stroke (AIS) after thrombolysis and its relationship with clinical outcomes[J].Rev Assoc Med Bras (1992),2018,64(5):438-442.
|
[40] |
Ribo M,Montaner J,Molina CA,et al.Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator[J].Stroke,2004,35(9):2123-2127.
|
[41] |
Caunca MR,Del Brutto V,Gardener H,et al.Cerebral microbleeds,vascular risk factors,and magnetic resonance imaging markers:northern manhattan study[J].J Am Heart Assoc,2016,5(9):179-186.
|
[42] |
Ovbiagele B,Liebeskind DS,Pineda S,et al.Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack[J].Arch Neurol,2010,67(1):45-50.
|
[43] |
Wang BR,Ou Z,Jiang T,et,al.Independent correlation of serum homocysteine with cerebral microbleeds in patients with acute ischemic stroke due to large-artery atherosclerosis[J].J Stroke Cerebrovasc Dis,2016,25(11):2746-2751.
|
[44] |
Nam KW,Kwon HM,Jeong HY,et al.Serum homocysteine level is related to cerebral small vesseldisease in a healthy population[J]. Neurology,2019,92(4):317-325.
|